Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

Journal of Laryngology and Otology

Volumn 122, Issue 8, 2008, Pages 848-853

  Choi, Y J ^a   Chung, J S ^a   Shin, H J ^a   Cho, G J ^a   Wang, S G ^a   Lee, B J ^a   Cho, B M ^a   Joo, Y D ^b   Sohn, C H ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Inje University   (South Korea)

Author keywords

Anti Neoplastic Agents; Cisplatin; Head and Neck Neoplasms; Toxicity

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; CREATININE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DISTANT METASTASIS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LETHARGY; LEUKOPENIA; MALE; MOUTH CARCINOMA; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; OROPHARYNX CARCINOMA; PATIENT COMPLIANCE; RADIATION DOSE; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXONIC ACID; REMISSION INDUCTION; TEGAFUR; TREATMENT OUTCOME;

EID: 47549085958     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107001181     Document Type: Article

References (25)

1. Forastiere AA, Koch W, Trotti A, Sidransky D. Medical progress: head and neck cancer. N Engl J Med 2001;345:1890-900
2. Posner MR, Haddad RI, Wirth L, Norris MR, Goguen LA, Mahadevan A et al. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. Semin Oncol 2004;31:778-85
3. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55
4. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collete L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890-8
5. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrisson W et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8
6. Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-9
7. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-6
8. Depondt J, Gehanno P, Martin M, Leievre G, Guerrier B, Peytral S et al. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 1993;50:23-7
9. Domenge C, Hill C, Lefebvre JL, De Raucourt D, Rhein B, Wibault P et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 2000;83:1594-8
10. Monnerat C, Faivre S, Temam S, Bourhis J, Raymond E. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 2002;13:995-1006
11. Rooney M, Kish J, Jacobs J, Kinzie J, Weaver A, Crissman J et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985;55:1123-8
12. Janinis J, Papadakou M, Panagos G, Panousaki A, Georgoulias V, Hatzidaki D et al. Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer. Am J Clin Oncol 2001;24:227-31
13. Schrijvers D, Van Herpen C, Kerger J, Joosens E, Van Laser C, Awada A et al. Docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. Ann Oncol 2004;15:638-45
14. Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y et al. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck. Int J Clin Oncol 2004;9:161-6
15. Watanabe A, Taniguchi M, Sasaki S. Induction chemotherapy with docetaxel, cisplatin, fluorouracil and 1-leucovorin for locally advanced head and neck cancer: a modified regimen for Japanese patients. Anticancer Drugs 2003;14:801-7
16. Schoffski P. The modulated oral fluropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. Anticancer Drugs 2004;15:85-106
17. Mpotassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 1996;56:2602-6
18. Shirasaka T, Shimamoto Y, Fukushima M. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res 1993;53:4004-9
19. Inuyama Y, Kida A, Tsukuda M, Kohno N, Satake B. Late phase II study of S-1 in patients with advanced head and neck cancer [in Japanese]. Gan To Kagaku Ryoho 2001;28:1381-90
20. Perez A, Brady W. Chemoirradiation in head and neck cancer: a review - part I. PRRO Updates 2(2), 2001; Part II. Lippincott Williams and Wilkins PRRO updates 2(3), 2001
21. Posner MR, Colevas AD, Tishler RB. The role of induction chemotherapy in the curative treatment of squamous cell carcinoma of the head and neck. Semin Oncol 2000;27(suppl G):13-24
22. Posner MR, Glisson B, Frenette G, Al-Sarrat M, Colevas AD, Norris CM et al. A multi-center phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 2001;19:1096-104
23. Spaulding B, Fischer G, Wolf T. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 1994;12:1592-9
24. Specht L, Larsen SK, Hansen HS. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Ann Oncol 2000;11:845-9
25. Fonseca E, Grau JJ, Stastre J, Garcia-Gomez JM, Rueda A, Pastor M et al. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. Eur J Cancer 2005;41:1254-60